Results 211 to 220 of about 247,999 (295)

Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics. [PDF]

Neurotherapeutics
Pieper AA, Lee FS.
europepmc   +1 more source

Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. [PDF]

Genes (Basel)
Kalak M, Brylak-Błaszków A, Błaszków Ł, Kalak T.   +3 more
europepmc   +1 more source

Protective effect of cannabinoid type II receptor ligand on bleomycin-induced pulmonary fibrosis in mice. [PDF]

PLoS One
Cao C, Wang RL, Guo CX, Xu XW, Wei JH, Cheng WZ, Yu YZ, Shi JJ, Feng ZW, Chen Y.   +9 more
europepmc   +1 more source

Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice [PDF]

, 2015
Aliczki, Manó, Balogh, Zoltán, Haller, József, Varga, Zoltán Kristóf   +3 more
core  

Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation. [PDF]

ACS Bio Med Chem Au
Yadav TC, Swaminathan LI, Chirasani VR, Wu Z, Lu D, Ignatowska-Jankowska BM, Lichtman AH, Fitting S, Yadav-Samudrala BJ.   +8 more
europepmc   +1 more source

The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas. [PDF]

Int J Mol Sci
Serefko A, Lachowicz-Radulska J, Jach ME, Świąder K, Szopa A.   +4 more
europepmc   +1 more source

Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis. [PDF]

Drug Des Devel Ther
Pan Z, Zerehpoosh S, Wang SC, Örmeci N, Kim W, Eslam M.   +5 more
europepmc   +1 more source

Levodopa-induced dyskinesia in Parkinson's disease: an updated review of pharmacological treatments. [PDF]

Front Aging Neurosci
Chen F, Zhou C.
europepmc   +1 more source